Assessment of embryo viability in assisted reproductive technology: Shortcomings of current approaches and the emerging role of metabolomics

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 3, 2008, Pages 234-241

  Bromer, Jason G ^a   Seli, Emre ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Assisted reproductive technology; Embryo assessment; Embryo metabolism; Metabolomics; Multiple pregnancies

Indexed keywords

AMINO ACID; GLUCOSE; LACTIC ACID; OXYGEN; PYRUVIC ACID;

AMINO ACID METABOLISM; BIRTH RATE; COST BENEFIT ANALYSIS; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; EMBRYO SEGMENTATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GLUCOSE METABOLISM; GROWTH RETARDATION; HEALTH CARE COST; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; METABOLOMICS; MORPHOLOGY; MULTIPLE PREGNANCY; NIDATION; NON INVASIVE MEASUREMENT; OXYGEN CONSUMPTION; PREGNANCY RATE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TREATMENT FAILURE; TWIN PREGNANCY;

AMINO ACIDS; BLASTOCYST; FEMALE; GLUCOSE; HUMANS; METABOLISM; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 43149121764     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3282fe723d     Document Type: Review

References (70)

1. Benyamini Y, Gozlan M, Kokia E. Variability in the difficulties experienced by women undergoing infertility treatments. Fertil Steril 2005; 83:275-283.
2. Mosher W, Pratt W. Fecundity and infertility in the United States 1965-88. In: Advance Data from Vital and Health Statistics No. 192. U.S. National Center for Health Statistics (NCHS); 4 December 1990. Publication order number DHHS (PHS) 91-1250. p. 9.
3. Society for Assisted Reproductive Technology. Assisted reproductive technology success rates. National summary and fertility clinic reports. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
4. European Society for Human Reproduction and Embryology. World Report on ART (assisted reproductive technology). Prague, Czech Republic; 2006.
5. Society for Assisted Reproductive Technology. Assisted reproductive technology success rates. National summary and fertility clinic reports. Atlanta, GA: Centers for Disease Control and Prevention; 2001.
6. Kovalevsky G, Patrizio P. High rates of embryo wastage with use of assisted reproductive technology: a look at the trends between 1995 and 2001 in the United States. Fertil Steril 2005; 84:325-330.
7. El-Toukhy T, Khalaf Y, Al-Darazi K, et al. Cryo-thawed embryos obtained from conception cycles have double the implantation and pregnancy potential of those from unsuccessful cycles. Hum Reprod 2003; 18:1313-1318.
8. Toner JP, Veeck LL, Acosta AA, Muasher SJ. Predictive value of pregnancy during original in vitro fertilization cycle on implantation and pregnancy in subsequent cryothaw cycles. Fertil Steril 1991; 56:505-508.
9. Wright VJC, Jeng G, Macaluso M. Assisted reproductive technology surveillance: United States, 2003. MMWR Surveil Summ 2006; 55:1-22.
10. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 2007; 109:967-977. This review summarizes the findings of a National Institute of Child Health and Human Development workshop, outlining the known risks involved with ART, including multiple pregnancies.
11. Luke B, Martin JA. The rise in multiple births in the United States: who, what, when, where, and why. Clin Obstet Gynecol 2004; 47:118-133.
12. Keith LG, Oleszczuk JJ, Keith DM. Multiple gestation: reflections on epidemiology, causes, and consequences. Int J Fertil Womens Med 2000; 45:206-214.
13. Yokoyama Y, Shimizu T, Hayakawa K. Prevalence of cerebral palsy in twins, triplets and quadruplets. Int J Epidemiol 1995; 24:943-948.
14. Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993; 307:1239-1243.
15. Skrablin S, Kuvacic I, Pavicic D, et al. Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations. Eur J Obstet Gynecol Reprod Biol 2000; 88:147-152.
16. Kilpatrick SJ, Jackson R, Croughan-Minihane MS. Perinatal mortality in twins and singletons matched for gestational age at delivery at > or = 30 weeks. Am J Obstet Gynecol 1996; 174:66-71.
17. Chelmow D, Penzias AS, Kaufman G, Cetrulo C. Costs of triplet pregnancy. Am J Obstet Gynecol 1995; 172:677-682.
18. Luke B, Bigger HR, Leurgans S, Sietsema D. The cost of prematurity: a case-control study of twins vs singletons. Am J Public Health 1996; 86:809-814.
19. Behrman, RE, Butler AS, editors. Preterm Birth: Causes, Consequences, and Prevention. Washington, D.C.: Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Board on Health Sciences Policy, Institute of Medicine of the National Academies; 2006.
20. Albrecht JL, Tomich PG. The maternal and neonatal outcome of triplet gestations. Am J Obstet Gynecol 1996; 174:1551-1556.
21. Haas JS, Berman S, Goldberg AB, et al. Prenatal hospitalization and compliance with guidelines for prenatal care. Am J Public Health 1996; 86:815-819.
22. Thurin A, Hausken J, Hillensjo T, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med 2004; 351:2392-2402.
23. Lukassen HG, Braat DD, Wetzels AM, et al. Two cycles with single embryo transfer versus one cycle with double embryo transfer: a randomized controlled trial. Hum Reprod 2005; 20:702-708.
24. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2:366.
25. Trounson AO, Mohr LR, Wood C, Leeton JF. Effect of delayed insemination on in-vitro fertilization, culture and transfer of human embryos. J Reprod Fertil 1982; 64:285-294.
26. Edwards RG, Fishel SB, Cohen J, et al. Factors influencing the success of in vitro fertilization for alleviating human infertility. J In Vitro Fertil Embryo Transfer 1984; 1:3-23.
27. Scott LA, Smith S. The successful use of pronuclear embryo transfers the day following oocyte retrieval. Hum Reprod 1998; 13:1003-1013.
28. Tesarik J, Greco E. The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod 1999; 14:1318-1323.
29. Veeck L. An atlas of human gametes and conceptuses: an illustrated reference for assisted reproductive technology. New York, USA: Parthenon Publishing; 1999.
30. Gerris J, De Neubourg D, Mangelschots K, et al. Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial. Hum Reprod 1999; 14:2581-2587.
31. Van Royen E, Mangelschots K, De Neubourg D, et al. Characterization of a top quality embryo, a step towards single-embryo transfer. Hum Reprod 1999; 14:2345-2349.
32. Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Towards reproductive certainty: fertility and genetics beyond 1999. Carnforth: Parthenon Publishing; 1999. pp. 378-388.
33. Toner JP. Progress we can be proud of: U.S. trends in assisted reproduction over the first 20 years. Fertil Steril 2002; 78:943-950.
34. Sakkas D, Gardner DK. Noninvasive methods to assess embryo quality. Curr Opin Obstet Gynecol 2005; 17:283-288.
35. Biggers JD, Whittingham DG, Donahue RP. The pattern of energy metabolism in the mouse oocyte and zygote. Proc Natl Acad Sci U S A 1967; 58:560-567.
36. Conaghan J, Handyside AH, Winston RM, Leese HJ. Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro. J Reprod Fertil 1993; 99:87-95.
37. Hardy K, Hooper MA, Handyside AH, et al. Noninvasive measurement of glucose and pyruvate uptake by individual human oocytes and preimplantation embryos. Hum Reprod 1989; 4:188-191.
38. Gott AL, Hardy K, Winston RM, Leese HJ. Noninvasive measurement of pyruvate and glucose uptake and lactate production by single human preimplantation embryos. Hum Reprod 1990; 5:104-108.
39. Conaghan J, Hardy K, Handyside AH, et al. Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology. J Assist Reprod Genet 1993; 10:21-30.
40. Turner K, Martin KL, Woodward BJ, et al. Comparison of pyruvate uptake by embryos derived from conception and nonconception natural cycles. Hum Reprod 1994; 9:2362-2366.
41. Gardner DK, Lane M, Stevens J, Schoolcraft WB. Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential. Fertil Steril 2001; 76:1175-1180.
42. Devreker F. Uptake and release of metabolites in human preimplantation embryos. In: Cohen J, Elder K, editors. Human preimplantation embryo selection. London, UK: Taylor and Francis; 2007. pp. 325-336.
43. Renard JP, Philippon A, Menezo Y. In-vitro uptake of glucose by bovine blastocysts. J Reprod Fertil 1980; 58:161-164.
44. Gardner DK, Leese HJ. Assessment of embryo viability prior to transfer by the noninvasive measurement of glucose uptake. J Exp Zool 1987; 242:103-105.
45. Lane M, Gardner DK. Selection of viable mouse blastocysts prior to transfer using a metabolic criterion. Hum Reprod 1996; 11:1975-1978.
46. Jones GM, Trounson AO, Vella PJ, et al. Glucose metabolism of human morula and blastocyst-stage embryos and its relationship to viability after transfer. Reprod Biomed Online 2001; 3:124-132.
47. Lane M, Gardner DK. Amino acids and vitamins prevent culture-induced metabolic perturbations and associated loss of viability of mouse blastocysts. Hum Reprod 1998; 13:991-997.
48. Houghton FD, Hawkhead JA, Humpherson PG, et al. Noninvasive amino acid turnover predicts human embryo developmental capacity. Hum Reprod 2002; 17:999-1005.
49. Brison DR, Houghton FD, Falconer D, et al. Identification of viable embryos in IVF by noninvasive measurement of amino acid turnover. Hum Reprod 2004; 19:2319-2324.
50. Seli E, Sakkas D, Scott R, et al. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization. Fertil Steril 2007; 88:1350-1357. This paper represents the first prospective trial evaluating metabolomic profiling as a method of embryo assessment and provides compelling evidence for the utility of this rapid, noninvasive technique.
51. Ellis DI, Goodacre R. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 2006; 131:875-885.
52. Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics 2006; 6:4716-4723.
53. Oldiges M, Lutz S, Pflug S, et al. Metabolomics: current state and evolving methodologies and tools. Appl Microbiol Biotechnol 2007; 76:495-511.
54. Lasch P, Chiriboga L, Yee H, Diem M. Infrared spectroscopy of human cells and tissue: detection of disease. Technol Cancer Res Treat 2002; 1:1-7.
55. Lasch P, Pacifico A, Diem M. Spatially resolved IR microspectroscopy of single cells. Biopolymers 2002; 67:335-338.
56. Wong PT, Wong RK, Caputo TA, et al. Infrared spectroscopy of exfoliated human cervical cells: evidence of extensive structural changes during carcinogenesis. Proc Natl Acad Sci U S A 1991; 88:10988-10992.
57. Scott R, Seli E, Miller K, et al. Non-invasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study. Fertil Steril (in press).
58. Kato O, Terramoto S, Morita H, et al. Metabolomic assessment of day2 embryos based on pregnancy outcome after single embryo transfer (SET). Presented at the annual meeting of the American Society for Reproductive Medicine 2007.
59. Vergouw CG, Lambalk CB, Lens J, et al. Noninvasive method for embryo selection in single embryo transfer (SET) using metabolomic profiling (MetPro) of oxidative metabolism (OM). Presented at the annual meeting of the American Society for Reproductive Medicine 2007.
60. Seli E, Botros L, Sakkas D, Burns DH. Noninvasive metabolomic profiling of human embryo culture media using H NMR correlates with pregnancy outcome. Presented at the 55th annual meeting of the Society for Gynecologic Investigation 2008.
61. Katz-Jaffe MG, Gardner DK. Embryology in the era of proteomics. Theriogenology 2007; 68 (Suppl 1):S125-S130. This review introduces the concept of proteomic analysis of the embryonic secretome, which may lead to the development of a noninvasive viability assay to assist in the selection of embryos for transfer.
62. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006; 86:678-685.
63. Sher G, Keskintepe L, Nouriani M, et al. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. Reprod Biomed Online 2004; 9:74-78.
64. Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil Steril 1996; 65:997-1002.
65. Jurisicova A, Casper RF, MacLusky NJ, et al. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci U S A 1996; 93:161-165.
66. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248:220-223.
67. Noci I, Fuzzi B, Rizzo R, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005; 20:138-146.
68. Yie SM, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 2005; 83:30-36.
69. Leese HJ. What does an embryo need? Hum Fertil (Camb) 2003; 6:180-185.
70. Lopes AS, Greve T, Callesen H. Quantification of embryo quality by respirometry. Theriogenology 2007; 67:21-31.